Rabeprazole sodium enteric-coated tablets can be taken for a long period of time as prescribed by the doctor, but the chance of adverse reactions increases with long-term use. Rabeprazole sodium enteric-coated tablets is a proton pump inhibitor, through the inhibition of gastric mucosal H-K-ATP (proton pump) enzyme, inhibit the synthesis and secretion of gastric acid, applicable to gastric ulcer, duodenal ulcer, reflux esophagitis, Drewe – Ai’s syndrome and other diseases of the treatment. The course of medication is usually 1-2 weeks for chronic gastritis, 4-8 weeks for peptic ulcer, and 4-8 weeks for reflux esophagitis. Rabeprazole sodium enteric-coated tablets in the process of taking will appear in the whole blood cell reduction, hemolytic anemia, dizziness, jaundice, diarrhea, skin rash and other adverse reactions, long-term use, the incidence of the above adverse reactions will increase accordingly. This product is contraindicated in those who are allergic to rabeprazole, benzimidazole metabolites or excipients, blood and liver function should be monitored in the course of administration, and the emergence of serious intolerable adverse reactions should be promptly consulted. Rebeprazole sodium enteric-coated tablets have drug-related effects with ribavirin, itraconazole, etc., and should be applied under doctor’s supervision to avoid adverse effects.